EDAP reports record Q4 HIFU revenue $12.9-13.3M; issues 2026 guidance $50-54M

EDAP TMS SA

2025-FY EPS reported -$0.78 revenue$70,527,000

Q4 HIFU revenue $12.9-13.3M (record); FY2025 HIFU revenue $36.7-37.2M, up 36-38% YoY.
15 Focal One systems placed in Q4; FY2025 placements up 69% YoY.
US Focal One procedures grew 28% YoY in Q4; 87 systems installed globally as of Dec 31, 2025.
2026 HIFU revenue guidance $50-54M; non-core revenue guided $22-26M.
CEO highlights accelerating demand, clinical validation from HIFI and FARP trials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.